The researchers found that AMPK activated by metformin preconditioning can effectively reduce the disorder of glucose and lipid metabolism, cellular oxidative stress, and renal function damage in diabetic rats through the SIRT1-dependent pathway, which has a protective effect on the pathological process of diabetes and diabetic nephropathy (Ren et al., 2020). The gene discussed is SIRT1; the disease is diabetes mellitus.